// App-Quantinova.ai

5072 : Indentification of a CTC-based gene expression signature predicting resistance to abiraterone and enzalutamide in mCRPC.

Researchers

Presenter

  • Todd Matthew Morgan

Principal Investigators

  • Jae-Seung Chung

  • Yugang Wang

  • James Henderson

  • Udit Singhal

  • Yuanyuan Qiao

  • Alexander Zaslavsky

  • Daniel H Hovelson

  • Ajjai Shivaram Alva

  • Felix Yi-Chung Feng

  • Ganesh S. Palapattu

  • Russell S. Taichman

  • Arul M. Chinnaiyan

  • Scott A. Tomlins

Medical Centers

  • University of Michigan, Ann Arbor, MI

  • Department of Urology, University of Michigan, Ann Arbor, MI

  • Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI

  • Department of Periodontics and Oral Medicine, Ann Arbor, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Prostate specific antigen

Drug/Treatment

  • Enzalutamide

  • CB-7598

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved